Caricamento...
Current State of Commercial Point-of-Care Nucleic Acid Tests for Infectious Diseases
The COVID-19 pandemic has put the spotlight on the urgent need for integrated nucleic acid tests (NATs) for infectious diseases, especially those that can be used near patient (“point-of-care”, POC), with rapid results and low cost, but without sacrificing sensitivity or specificity of gold standard...
Salvato in:
| Pubblicato in: | Analyst |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8139840/ https://ncbi.nlm.nih.gov/pubmed/33899053 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/d0an01988g |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|